Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2014

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • investor1989I Offline
    investor1989I Offline
    investor1989
    wrote on sidst redigeret af
    #532

    Den danske opdagelse handler om at bekæmpe blærekræft, men gruppen har gjort lignende fund inden for tyktarmskræft.

    1 Reply Last reply
    0
    • investor1989I Offline
      investor1989I Offline
      investor1989
      wrote on sidst redigeret af
      #533

      man målretter - dvs. sprøjter direkte ind i canceren dvs. det lyder typisk som forsøg mod solid tumors. Så ikke konkurrent til andet end Humax-TF-ADC pt. Men nu er det jo meeeeeeeeeeeeega early og mange mange mange år ude i fremtiden selv hvis det giver succes i klinikken også

      1 Reply Last reply
      0
      • investor1989I Offline
        investor1989I Offline
        investor1989
        wrote on sidst redigeret af
        #534

        Det er mere positivt for Exiqon fordi det sætter fokus på RNA forskning som de sælger reagenser til.

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #535

          Lyder det ikke mere til at være et "toxin" til ADC teknologien, det det skal ind i cancercellerne ?

          1 Reply Last reply
          0
          • 1 Offline
            1 Offline
            120281
            wrote on sidst redigeret af
            #536

            Update fra J.P Morgan http://medwatch.dk/Medicinal___Biotek/article6413398.ece?utm_source=Feed&utm_medium=top&utm_campaign=Morgen&utm_content=2014-01-20+08%3A13%3A00

            1 Reply Last reply
            0
            • 1 Offline
              1 Offline
              120281
              wrote on sidst redigeret af
              #537

              Interessant: Kvalitetsjournalistik kræver investeringer. Del venligst denne artikel med andre ved at bruge nedenstående link. http://medwatch.dk/Medicinal___Biotek/article6413398.ece?utm_source=Feed&utm_medium=top&utm_campaign=Morgen&utm_content=2014-01-20+08%3A13%3A00#ixzz2qvZb9XlE
              Kopier og videresend ikke artiklen. Det er i strid med ophavsretsloven og vores abonnementsbetingelser: http://medwatch.dk/service/betingelser

              Samtidig mener Bruce Booth, at aktiviteterne og snakken på konferenc

              1 Reply Last reply
              0
              • investor1989I Offline
                investor1989I Offline
                investor1989
                wrote on sidst redigeret af
                #538

                Link Preview Image
                JPM 2014: Broad Optimism About Biotech Innovation - LifeSciVC

                The annual biotech pilgrimage to San Francisco has come to an end, and the upbeat, optimistic sentiment from #JPM14 bodes well as a barometer of the healthcare industry. Amidst the presentations and partying, there was lots of bullish thinking about

                favicon

                LifeSciVC (lifescivc.com)

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  gentogen
                  wrote on sidst redigeret af
                  #539

                  Link Preview Image
                  PAGE NOT FOUND | J.P. Morgan

                  favicon

                  (www.jpmorgan.com)

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    gentogen
                    wrote on sidst redigeret af
                    #540

                    In FY2013 (Oct 2012 to Sep 2013) 103 requests for breakthrough designation were
                    made with 32 requests granted and 62 denied

                    1 Reply Last reply
                    0
                    • G Offline
                      G Offline
                      gentogen
                      wrote on sidst redigeret af
                      #541

                      We continue to believe
                      that the biotech industry is in the early innings of an innovation cycle with many labelexpansion
                      opportunities and novel agents in phase 2 or 3 trials that are largely
                      unaccounted for in Street models. Hence, we are bullish on the group for 2014.

                      1 Reply Last reply
                      0
                      • 1 Offline
                        1 Offline
                        120281
                        wrote on sidst redigeret af
                        #542

                        Genmab måtte da gerne have været nævnt.

                        1 Reply Last reply
                        0
                        • 1 Offline
                          1 Offline
                          120281
                          wrote on sidst redigeret af
                          #543

                          Kan så se Janssen og GSK står på med Gen produkterne under BTD

                          1 Reply Last reply
                          0
                          • investor1989I Offline
                            investor1989I Offline
                            investor1989
                            wrote on sidst redigeret af
                            #544

                            Genmab er den usynlige engine der skaber produkterne 🙂 de andre tager fame for dem

                            1 Reply Last reply
                            0
                            • JørgenVarnæsJ Offline
                              JørgenVarnæsJ Offline
                              JørgenVarnæs
                              wrote on sidst redigeret af
                              #545

                              næh - gode nyheder. Kempen hæver kursmål fra 200 til 285

                              1 Reply Last reply
                              0
                              • 1 Offline
                                1 Offline
                                120281
                                wrote on sidst redigeret af
                                #546

                                Ja men stadig overrasket over fordelingen på 10 analytikere hedder 4 køb, 2 neutral og 4 negative. Men dejligt med en mere der justere til små 300.

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  JKY_VH
                                  wrote on sidst redigeret af
                                  #547

                                  God morgen

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Repsac
                                    wrote on sidst redigeret af
                                    #548

                                    Der er da heldigvis kommet lidt mere volumen i Gen i dag.

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #549

                                      Sydbank køber pænt igen

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        JKY_VH
                                        wrote on sidst redigeret af
                                        #550

                                        Mon deres analyse er ved at gå i trykken?

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #551

                                          Det kunne man da håbe 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger